On September 19, at the HUAWEI Innovative Product Launch event in Barcelona, Spain, Huawei Consumer Business Group (CBG) ...
Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the ...
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentationAdditionally, two posters on data from the pioneering use of tape stripping for biomarker ...